Cramer: The pipeline matters most
May 2, 2013
The pharmaceutical business is not about near-term estimates or earnings just reported--it's all about pipeline, what's in the works, what could be blockbuster.
Related Stories
Cramer: The pipeline matters most
May 2, 2013
The pharmaceutical business is not about near-term estimates or earnings just reported--it's all about pipeline, what's in the works, what could be blockbuster.
How the bears are playing Allergan
May 1, 2013
The drug maker broke out to new all-time highs in January and kept climbing through early last month, when it started drifting lower.
Premium Services
Semi-active traders looking for simple calls and spreads (5 per week).
Learn MoreEntry-to-mid level traders looking for full circle trade analysis (1 per week).
Learn MoreTailored, one-on-one education designed and led by Jon & Pete (3 months and up)
Learn More